Ocata Therapeutics Inc fka OCAT

[art2426]

I know, this cheesy form of PR does nothing but cheapen the possible reputation and proffesionalism of this company to those on Wall Street, thus hurting the significance of these trials and outcome. Rabin is, IMO, a joke, and further PR antics of such will not intice big $$. This (PR antics) only serve the individual small investor than can be schmoozed into buying this stock. It does absolutely nothing to attract institutional investors who can move the stock at will. That is why RESULTS are the only thing that matters if we are to see a nice rise in the stock price. Legitamacy is what they are looking for before investing big $$. If and when that occurs the price will reflect that. It is antics like this and "shady" decisions (IMO) by Rabin that have discouraged me from investing more $$ at this time. I will wait for legitimate (not chessy PRs) journal reviews to throw larger cash in this company. -- although I must say I am very tempted to put a little more into this game at, what I believe to be, a worthwhile purchase price of .06.